These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36323537)

  • 21. [Chinese Expert Consensus on Antiangiogenic Drugs for Advanced Non-small Cell Lung Cancer (2019 Edition)].
    Chinese Society of Clinical Oncology, Expert Committee on Vessel Targeted Therapy, Expert Committee on Non-small Cell Lung Cancer, Expert Group on Antiangiogenic Drugs for Non-small Cell Lung Cancer
    Zhongguo Fei Ai Za Zhi; 2019 Jul; 22(7):401-412. PubMed ID: 31315778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chinese expert consensus on antiangiogenic drugs for advanced non-small cell lung cancer (2020 Edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1063-1077. PubMed ID: 33342166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.
    Vansteenkiste J; Crinò L; Dooms C; Douillard JY; Faivre-Finn C; Lim E; Rocco G; Senan S; Van Schil P; Veronesi G; Stahel R; Peters S; Felip E;
    Ann Oncol; 2014 Aug; 25(8):1462-74. PubMed ID: 24562446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study.
    Wang S; Cui Z; Li H; Li J; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Zhou B; Yin Z
    Pathol Res Pract; 2019 Dec; 215(12):152723. PubMed ID: 31704150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China.
    Wang X; Su S; Li S; Bao H; Zhang M; Liu D; Jiang H; Wang J; Liu M
    BMC Cancer; 2017 Aug; 17(1):603. PubMed ID: 28859609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Guidelines on clinical practice of molecular tests in non-small cell lung cancer in China].
    ; ; ; ;
    Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):323-332. PubMed ID: 33831989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China.
    Korse CM; Holdenrieder S; Zhi XY; Zhang X; Qiu L; Geistanger A; Lisy MR; Wehnl B; van den Broek D; Escudero JM; Standop J; Hu M; Molina R
    Clin Chim Acta; 2015 Jan; 438():388-95. PubMed ID: 25262909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expert Consensus on Adjuvant Therapy of Non-small Cell Lung Cancer from China Thoracic Surgeons (2018 Version)].
    Thoracic Surgery Committee on Adjuvant Therapy of Non-small Cell Lung Cancer
    Zhongguo Fei Ai Za Zhi; 2018 Oct; 21(10):731-737. PubMed ID: 30309423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Consensus of Chinese experts on detection of related drive genes in target therapy of non-small cell lung cancer].
    Wang E; Zhu M; Bu H; Chen J; Ding Y; Zhou X; Liang Z; Zhang X; Sun B; ; ; ;
    Zhonghua Bing Li Xue Za Zhi; 2016 Feb; 45(2):73-7. PubMed ID: 26879425
    [No Abstract]   [Full Text] [Related]  

  • 30. Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.
    Zhu B; Yan Y; Shao B; Tian L; Zhou W
    J Int Med Res; 2018 Apr; 46(4):1517-1527. PubMed ID: 29363378
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
    Ther Adv Respir Dis; 2020; 14():1753466620918192. PubMed ID: 32401173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis reveals prognostic role of programmed death ligand-1 in Asian patients with non-small cell lung cancer.
    Hu XY; Zhang W; Hu Y; Zhang Y; Gong R; Liang JY; Liu L
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):313-320. PubMed ID: 27376797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules.
    Chen C; Huang X; Yin W; Peng M; Wu F; Wu X; Tang J; Chen M; Wang X; Hulbert A; Brock MV; Liu W; Herman JG; Yu F
    Clin Epigenetics; 2020 Mar; 12(1):39. PubMed ID: 32138766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung cancer late-detection, multimodality strategy.
    Grannis FW
    J Thorac Oncol; 2006 Jan; 1(1):105. PubMed ID: 17409836
    [No Abstract]   [Full Text] [Related]  

  • 35.
    Socinski MA; Pennell NA; Davies KD
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34036238
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-small cell lung cancer. Clinical practice guidelines in oncology.
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2004 Mar; 2(2):94-123. PubMed ID: 19777701
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of genetic polymorphisms in the paraoxonase 1 gene with the risk and prognosis of non-small cell lung cancer in Chinese Han population.
    Wang H; Li L; Ding L; Zhang Z; Pu C
    J Investig Med; 2012 Mar; 60(3):592-7. PubMed ID: 22367101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
    Park K; Vansteenkiste J; Lee KH; Pentheroudakis G; Zhou C; Prabhash K; Seto T; Voon PJ; Tan DSW; Yang JCH; Wang J; Babu KG; Nakayama Y; Alip A; Chua KLM; Cheng JC; Senan S; Ahn YC; Kim TY; Ahn HK; Peters S; Yoshino T; Douillard JY
    Ann Oncol; 2020 Feb; 31(2):191-201. PubMed ID: 31959336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.
    Brodowicz T; Ciuleanu T; Crawford J; Filipits M; Fischer JR; Georgoulias V; Gridelli C; Hirsch FR; Jassem J; Kosmidis P; Krzakowski M; Manegold C; Pujol JL; Stahel R; Thatcher N; Vansteenkiste J; Minichsdorfer C; Zöchbauer-Müller S; Pirker R; Zielinski CC;
    Ann Oncol; 2012 May; 23(5):1223-1229. PubMed ID: 21940784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Postmus PE; Kerr KM; Oudkerk M; Senan S; Waller DA; Vansteenkiste J; Escriu C; Peters S;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv1-iv21. PubMed ID: 28881918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.